Fundamental Analysis of BABYLON HOLDINGS LTD- CL A(NYSE:BBLN) stock

Fundamental Rating

Taking everything into account, BBLN scores 2 out of 10 in our fundamental rating. BBLN was compared to 40 industry peers in the Health Care Technology industry. Both the profitability and financial health of BBLN have multiple concerns. BBLN shows excellent growth, but is valued quite expensive already.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BBLN has reported negative net income.

BBLN had a negative operating cash flow in the past year.

1.2 Ratios

BBLN has negative profitability rations, so we won't be analyzing them here.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BBLN so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BBLN does not have a ROIC to compare to the WACC, probably because it is not profitable.

BBLN has more shares outstanding than it did 1 year ago.

The debt/assets ratio for BBLN is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -4.90, we must say that BBLN is in the distress zone and has some risk of bankruptcy.

BBLN has a worse Altman-Z score (-4.90) than 79.07% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-4.9

ROIC/WACCN/A

WACC4.64%

2.3 Liquidity

BBLN has a Current Ratio of 1.07. This is a normal value and indicates that BBLN is financially healthy and should not expect problems in meeting its short term obligations.

BBLN's Current ratio of 1.07 is on the low side compared to the rest of the industry. BBLN is outperformed by 62.79% of its industry peers.

A Quick Ratio of 1.07 indicates that BBLN should not have too much problems paying its short term obligations.

BBLN has a Quick ratio of 1.07. This is in the lower half of the industry: BBLN underperforms 62.79% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.07
Quick Ratio	1.07

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for BBLN have decreased strongly by -112.81% in the last year.

Looking at the last year, BBLN shows a very strong growth in Revenue. The Revenue has grown by 149.85%.

Measured over the past years, BBLN shows a very strong growth in Revenue. The Revenue has been growing by 310.57% on average per year.

EPS 1Y (TTM)-112.81%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q59.52%

Revenue 1Y (TTM)149.85%

Revenue growth 3Y310.57%

Revenue growth 5YN/A

Revenue growth Q2Q16.77%

3.2 Future

The Earnings Per Share is expected to grow by 21.15% on average over the next years. This is a very strong growth

BBLN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.34% yearly.

EPS Next Y57.13%

EPS Next 2Y32.22%

EPS Next 3Y21.15%

EPS Next 5YN/A

Revenue Next Year11.12%

Revenue Next 2Y9.08%

Revenue Next 3Y14.59%

Revenue Next 5Y31.34%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

BBLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BBLN. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as BBLN's earnings are expected to grow with 21.15% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y32.22%

EPS Next 3Y21.15%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BBLN does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BABYLON HOLDINGS LTD- CL A

NYSE:BBLN (6/28/2023, 7:04:01 PM)

After market: 0.5598 +0.01 (+1.71%)

0.5504

-0.09 (-13.99%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap14.08M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover9.5

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1.07
Quick Ratio	1.07
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-112.81%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y57.13%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)149.85%

Revenue growth 3Y310.57%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

BABYLON HOLDINGS LTD- CL A (BBLN)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens